RxDoctor Payments Data

Thomas Dickinson

Gastroenterology · Provo, UTNPI 1376591354

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 35.6% of the total. Reporting peaked in 2021 at $1,741 and has fallen 98.5% since, to $27 in 2025.

$3,869in general payments, 2019–2025

Across 263 payments — averaging $14.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$483
  • Gilead$279
  • Pfizer$271
  • Johnson & Johnson$257
  • Nestle Healthcare Nutrition Inc.$177
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,71696%
  • Education$1003%
  • Gifts$531%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,869 in reported general payments places this provider in the 60th percentile of 122 gastroenterology providers in Utah.

See all gastroenterology providers in Utah

Other gastroenterology in Provo

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →